Kymera Therapeutics to Host Virtual Immunology R&D Day on January 4

<p>Company to provide update on its emerging pipeline of high-value immunology programs WATERTOWN, Mass., Dec. 13, 2023 (GLOBE NEWSWIRE) &#8212; Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today shared webcast information for the virtual Immunology R&#38;D Day that the Company [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/kymera-therapeutics-to-host-virtual-immunology-rd-day-on-january-4/">Kymera Therapeutics to Host Virtual Immunology R&amp;D Day on January 4</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>